Hong Mei1, Zhen-Yu Lin, Qiang-Song Tong. 1. Department of Pediatric Surgery, Union Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.
Abstract
BACKGROUND: Neuroblastoma (NB) is the most common extracranial solid tumor in childhood and displays remarkable heterogeneity in clinical behaviors, ranging from spontaneous regression to rapid progression or resistance to multimodal treatment. Recent evidence has shown that microRNAs (miRNAs), a class of small non-coding RNAs, are involved in tumor development and progression. This article aimed to review recent advances in investigating the roles of miRNAs in NB. METHODS: We searched the PubMed/MEDLINE database for articles about the expression profile, functions and target genes of miRNAs in NB. RESULTS: We reviewed the most recent evidence regarding the functional roles of oncogenic and tumor suppressive miRNAs in NB and application of novel miRNA-based methods for diagnostic, prognostic and therapeutic purposes. CONCLUSIONS: Deregulation of miRNAs is associated with the development and progression of NB, suggesting that miRNAs may serve as novel targets for the treatment of high-risk NB patients. However, their precise functions and underlying mechanisms still warrant further studies.
BACKGROUND:Neuroblastoma (NB) is the most common extracranial solid tumor in childhood and displays remarkable heterogeneity in clinical behaviors, ranging from spontaneous regression to rapid progression or resistance to multimodal treatment. Recent evidence has shown that microRNAs (miRNAs), a class of small non-coding RNAs, are involved in tumor development and progression. This article aimed to review recent advances in investigating the roles of miRNAs in NB. METHODS: We searched the PubMed/MEDLINE database for articles about the expression profile, functions and target genes of miRNAs in NB. RESULTS: We reviewed the most recent evidence regarding the functional roles of oncogenic and tumor suppressive miRNAs in NB and application of novel miRNA-based methods for diagnostic, prognostic and therapeutic purposes. CONCLUSIONS: Deregulation of miRNAs is associated with the development and progression of NB, suggesting that miRNAs may serve as novel targets for the treatment of high-risk NB patients. However, their precise functions and underlying mechanisms still warrant further studies.
Authors: E A Afanasyeva; P Mestdagh; C Kumps; J Vandesompele; V Ehemann; J Theissen; M Fischer; M Zapatka; B Brors; L Savelyeva; V Sagulenko; F Speleman; M Schwab; F Westermann Journal: Cell Death Differ Date: 2011-01-14 Impact factor: 15.828
Authors: Jingbo Qiao; Sora Lee; Pritha Paul; Lauren Theiss; Joshua Tiao; Lan Qiao; Andrew Kong; Dai H Chung Journal: Surgery Date: 2013-06-24 Impact factor: 3.982
Authors: Jennifer Lynch; Joanna Fay; Maria Meehan; Kenneth Bryan; Karen M Watters; Derek M Murphy; Raymond L Stallings Journal: Carcinogenesis Date: 2012-03-01 Impact factor: 4.944
Authors: Amanda Tivnan; Wayne Shannon Orr; Vladimir Gubala; Robert Nooney; David E Williams; Colette McDonagh; Suzanne Prenter; Harry Harvey; Raquel Domingo-Fernández; Isabella M Bray; Olga Piskareva; Catherine Y Ng; Holger N Lode; Andrew M Davidoff; Raymond L Stallings Journal: PLoS One Date: 2012-05-25 Impact factor: 3.240
Authors: Johannes H Schulte; Tobias Marschall; Marcel Martin; Philipp Rosenstiel; Pieter Mestdagh; Stefanie Schlierf; Theresa Thor; Jo Vandesompele; Angelika Eggert; Stefan Schreiber; Sven Rahmann; Alexander Schramm Journal: Nucleic Acids Res Date: 2010-05-13 Impact factor: 16.971
Authors: Amanda Tivnan; Lorraine Tracey; Patrick G Buckley; Leah C Alcock; Andrew M Davidoff; Raymond L Stallings Journal: BMC Cancer Date: 2011-01-25 Impact factor: 4.430
Authors: C-H Gattolliat; L Thomas; S A Ciafrè; G Meurice; G Le Teuff; B Job; C Richon; V Combaret; P Dessen; D Valteau-Couanet; E May; P Busson; S Douc-Rasy; J Bénard Journal: Br J Cancer Date: 2011-10-04 Impact factor: 7.640
Authors: Paolo Neviani; Petra M Wise; Mariam Murtadha; Cathy W Liu; Chun-Hua Wu; Ambrose Y Jong; Robert C Seeger; Muller Fabbri Journal: Cancer Res Date: 2018-12-12 Impact factor: 12.701